vimarsana.com

Page 16 - குறிப்பு தொடர்பாக முன்னோக்கி பார்க்கிறது தகவல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Lesotho s Prime Minister Visits Bophelo as it Becomes the First Cannabis Company to Enter the Country s Special Economic Zone

Lesotho s Prime Minister Visits Bophelo as it Becomes the First Cannabis Company to Enter the Country s Special Economic Zone News provided by Share this article TORONTO, May 19, 2021 /CNW/ - Halo Collective Inc. ( Halo or the Company ) (NEO: HALO) (OTC: HCANF) (Germany: A9KN) is pleased to announce that its wholly-owned subsidiary Bophelo Bioscience & Wellness (Pty) Ltd. ( Bophelo ) today welcomed Lesotho s Prime Minister, The Rt. Honorable Dr. Moeketse Majoro and six of his Cabinet Ministers to tour Bophelo s site. Ms. Louisa Mojela, the Executive Chairman of Halo and the Founder and Chairman of Bophelo, affirmed the groundbreaking opportunity created by the Lesotho Government by being the first country on the African continent to legalize the growing and cultivation of medicinal cannabis. On behalf of Halo and Bophelo, Ms. Mojela expressed her most profound gratitude for the Prime Minister and his cabinet s momentous visit. This important milestone for the country has

Medipure Holdings Inc Announces a Filing of its Provisional Patent for Psoriasis Treatment

Medipure Holdings Inc. Announces a Filing of its Provisional Patent for Psoriasis Treatment Share Article Treatment for Inflammatory Skin Conditions Added to Innovative Pharmaceutical Company’s Portfolio of Prescription Medications This is an exciting time for Medipure given our business development and growth, and developing MP-30X has strengthened our portfolio of drugs pipeline and I am grateful for our superb team and all they have done and continue to do. VANCOUVER, British Columbia (PRWEB) May 19, 2021 Medipure Pharmaceuticals Inc. (“MPI”), a wholly owned subsidiary of Medipure Holdings Inc. (together with MPI, “Medipure” or the “Company”), a biopharmaceutical incubator committed to discovering and developing proprietary prescription drugs focused on the endocannabinoid system, is pleased to announce the submission of provisional patent application to the United States Patent and Trademar

Synex International Inc Third Quarter of Fiscal 2021

Synex International Inc. Third Quarter of Fiscal 2021 Company or Synex ) is pleased to announce its financial and operational results for the three months ended March 31, 2021 ( Q3 2021 ). Revenue for Q3 2021 increased to $1,058,954 from $1,049,390 in Q3 2020 . Electricity sales from Q3 2021 were $1,031,486 compared with $1,022,392 in the three months ended March 31, 2020 ( Q3 2020 ), which is an increase of $9,094. The increase in revenue for Q3 2021 was mainly due to higher power sales with respect to the Mears, Cypress and Barr hydroelectric plants. The net income attributable to shareholders of the Company in Q3 2021 was $264,476 as compared to net income of $216,740 in Q3 2020. The net income per share in Q3 2021 was $0.01 as compared to an income of $0.01 in Q3 2020.

Western Uranium & Vanadium Reports Warrant Exercise of C$2 Million

Western Uranium & Vanadium Reports Warrant Exercise of C$2 Million Western Uranium & Vanadium Corp. is pleased to announce that 1,706,570 warrants were exercised and 1,706,570 shares were issued in April and May 2021. The Warrant Exercise raised cumulative gross proceeds of C$1,966,059.  Western currently has a total of 38,165,317 common shares outstanding. The Warrant Exercise predominantly included warrants issued in private placements which closed in July and August 2018 for a … Western Uranium & Vanadium Corp. (CSE: WUC) (OTCQX: WSTRF) (“ Western ” or the ” Company ”) is pleased to announce that 1,706,570 warrants were exercised (the “Warrant Exercise”) and 1,706,570 shares were issued in April and May 2021. The Warrant Exercise raised cumulative gross proceeds of C$1,966,059.  Western currently has a total of 38,165,317 common shares outstanding.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.